Winton Group LTD Vanda Pharmaceuticals Inc. Transaction History

Winton Group LTD

$1.31 Billion
Q3 2024

A detailed history of Winton Group LTD transactions in Vanda Pharmaceuticals Inc. stock. As of the latest transaction made, Winton Group LTD holds 72,465 shares of VNDA stock, worth $368,846. This represents 0.03% of its overall portfolio holdings.

Number of Shares

72,465

Previous 113,483 36.14%

Holding current value

$368,846

Previous $641,000 47.11%

% of portfolio

0.03%

Previous 0.05%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	SELL	$4.61 - $6.34 $189,092 - $260,054	-41,018 Reduced 36.14%	72,465 $339,000
Q2 2024 Aug 09, 2024	SELL	$3.91 - $6.5 $196,841 - $327,229	-50,343 Reduced 30.73%	113,483 $641,000
Q1 2024 May 14, 2024	BUY	$3.47 - $4.61 $176,046 - $233,883	50,734 Added 44.86%	163,826 $673,000
Q4 2023 Feb 12, 2024	BUY	$3.38 - $4.58 $86,524 - $117,243	25,599 Added 29.26%	113,092 $477,000
Q3 2023 Nov 13, 2023	BUY	$4.28 - $6.57 $9,814 - $15,065	2,293 Added 2.69%	87,493 $377,000
Q2 2023 Aug 14, 2023	BUY	$5.9 - $6.95 $114,052 - $134,350	19,331 Added 29.35%	85,200 $561,000
Q1 2023 May 12, 2023	SELL	$6.18 - $7.99 $31,474 - $40,693	-5,093 Reduced 7.18%	65,869 $447,000
Q4 2022 Feb 14, 2023	BUY	$6.87 - $10.96 $120,808 - $192,731	17,585 Added 32.94%	70,962 $524,000
Q3 2022 Nov 10, 2022	SELL	$9.44 - $11.76 $224,719 - $279,946	-23,805 Reduced 30.84%	53,377 $527,000
Q2 2022 Aug 10, 2022	BUY	$9.31 - $11.84 $549 - $698	59 Added 0.08%	77,182 $841,000
Q1 2022 May 11, 2022	BUY	$10.84 - $16.55 $217,894 - $332,671	20,101 Added 35.25%	77,123 $872,000
Q4 2021 Feb 10, 2022	SELL	$15.69 - $21.14 $208,206 - $280,527	-13,270 Reduced 18.88%	57,022 $895,000
Q3 2021 Oct 28, 2021	SELL	$15.35 - $21.27 $173,240 - $240,053	-11,286 Reduced 13.83%	70,292 $1.21 Million
Q2 2021 Aug 10, 2021	SELL	$15.71 - $21.51 $130,848 - $179,156	-8,329 Reduced 9.26%	81,578 $1.76 Million
Q1 2021 Jul 21, 2021	SELL	$13.42 - $20.28 $121,451 - $183,534	-9,050 Reduced 9.15%	89,907 $1.35 Million
Q4 2020 Feb 12, 2021	SELL	$9.77 - $13.81 $1.74 Million - $2.46 Million	-178,244 Reduced 64.3%	98,957 $1.3 Million
Q3 2020 Oct 30, 2020	SELL	$9.32 - $12.02 $2.87 Million - $3.7 Million	-308,047 Reduced 52.64%	277,201 $2.68 Million
Q2 2020 Aug 05, 2020	BUY	$9.66 - $12.02 $209,863 - $261,134	21,725 Added 3.86%	585,248 $6.7 Million
Q1 2020 May 11, 2020	BUY	$7.5 - $16.8 $81,622 - $182,834	10,883 Added 1.97%	563,523 $5.84 Million
Q4 2019 Feb 13, 2020	BUY	$12.38 - $17.47 $6.56 Million - $9.25 Million	529,686 Added 2307.6%	552,640 $9.07 Million
Q3 2019 Nov 08, 2019	BUY	$12.27 - $15.79 $281,645 - $362,443	22,954 New	22,954 $305,000

Others Institutions Holding VNDA

# of Institutions

161

Shares Held

45.2M

Call Options Held

165K

Put Options Held

33.6K

View Full List

About Vanda Pharmaceuticals Inc.

Ticker VNDA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 56,561,500
Market Cap $288M
Description
Vanda Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of therapies to address high unmet medical needs. The company's marketed products include HETLIOZ for the treatment of non-24-hour sleep-wake disorders; and Fanapt oral tablets for the treatment of schizophrenia. Its products under developme...

More about VNDA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Winton Group LTD, based on Form 13F filings with the SEC.

News

Stay updated on Winton Group LTD with notifications on news.

Account